RM1.25mil boost for AIDS foundation

Prof Dr Adeeba (left) receiving the contribution from Burden during the launch of the partnership.

GLAXOSmithKline Pharmaceutical Sdn Bhd (GSK Malaysia) has earmarked RM1.25mil for the Malaysian AIDS Foundation (MAF) to advance three of its high-impact AIDS programmes over the next three years.

MAF chairman ​Prof Datuk Dr Adeeba Kamarulzaman received the funds on behalf of MAF from GSK Malaysia general manager and vice-president Ramil Burden at the official launch of the partnership.